title: Recent Advances in Endometrial Cancer.
abstract: Endometrial cancer is the most common gynecologic malignancy in the United States, with yearly rates continuing to increase. Most women present with early stage disease; however, advanced disease carries a grave prognosis. As a result, novel therapies are currently under investigation for the treatment of endometrial cancer. These advances include a better understanding of the genetic basis surrounding the development of endometrial cancer, novel surgical therapies, and new molecular targets for the treatment of this disease. This review explores the literature regarding these advancements in endometrial cancer.
authors.affiliation: Gynecologic Oncology, University of North Carolina at Chapel Hill, NC, USA.
authors.forename: Arthur-Quan
authors.initials: AQ
authors.lastname: Tran
authors.affiliation: Gynecologic Oncology, University of North Carolina at Chapel Hill, NC, USA.
authors.forename: Paola
authors.initials: P
authors.lastname: Gehrig
keywords: endometrial cancer; molecular targets; surgical therapies; treatment